Growth Metrics

Opus Genetics (IRD) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -51.77%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 24.73%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -28.55%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 13.33%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -16.07%
7 Evaxion A 62.56 Bn 62.54 Bn - 21.66%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.88%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 36.53%
10 Opus Genetics 357.99 Mn 298.03 Mn - 15.43%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.43%
Dec 31, 2025 1.89%
Sep 30, 2025 30.51%
Jun 30, 2025 23.96%
Mar 31, 2025 29.50%
Dec 31, 2024 7.31%
Sep 30, 2024 18.05%
Jun 30, 2024 19.55%
Mar 31, 2024 64.49%
Dec 31, 2023 45.49%
Sep 30, 2023 73.78%
Jun 30, 2023 63.16%
Mar 31, 2023 52.48%
Dec 31, 2022 202.71%
Sep 30, 2022 20.43%
Jun 30, 2022 32.55%
Mar 31, 2022 46.49%
Dec 31, 2021 41.04%
Sep 30, 2021 69.22%
Jun 30, 2021 68.18%
Mar 31, 2021 18.94%
Dec 31, 2020 22.60%
Sep 30, 2020 -0.60%
Jun 30, 2020 1.56%
Mar 31, 2020 1.60%
Dec 31, 2019 -48.99%
Sep 30, 2019 -1.86%
Jun 30, 2019 -2.46%
Mar 31, 2019 -16.36%
Dec 31, 2018 -5.00%
Sep 30, 2018 -28.29%
Jun 30, 2018 -20.06%
Mar 31, 2018 -16.27%
Dec 31, 2017 -3.25%
Sep 30, 2017 -18.10%
Jun 30, 2017 -38.67%
Mar 31, 2017 -36.04%
Dec 31, 2016 -14.75%
Sep 30, 2016 -17.36%
Jun 30, 2016 -7.58%
Mar 31, 2016 -4.65%
Dec 31, 2015 -8.89%
Sep 30, 2015 19.04%
Jun 30, 2015 5.53%
Mar 31, 2015 9.82%
Dec 31, 2014 -0.12%
Sep 30, 2014 4.24%
Jun 30, 2014 33.19%
Mar 31, 2014 25.01%
Dec 31, 2013 14.84%
Sep 30, 2013 -2.06%
Jun 30, 2013 -17.57%